We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+8.11%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.6B
AUM Growth
-$813M
Cap. Flow
-$1.34B
Cap. Flow %
-10.62%
Top 10 Hldgs %
15.55%
Holding
605
New
149
Increased
96
Reduced
113
Closed
185

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$269M
2
GE icon
GE Aerospace
GE
+$170M
3
ADI icon
Analog Devices
ADI
+$142M
4
KEY icon
KeyCorp
KEY
+$122M
5
MSI icon
Motorola Solutions
MSI
+$108M

Top Sells

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$213M
2
GGP
GGP Inc.
GGP
+$153M
3
GD icon
General Dynamics
GD
+$143M
4
ZBH icon
Zimmer Biomet
ZBH
+$119M
5
EQIX icon
Equinix
EQIX
+$104M

Sector Composition

Rank Sector Weight
1 Technology 17.04%
2 Industrials 16.34%
3 Healthcare 11.75%
4 Consumer Discretionary 11.52%
5 Financials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLR icon
326
Fluor
FLR
$6.81B
$2.21M 0.02%
+42,856
New +$2M
WLH
327
DELISTED
WILLIAM LYON HOMES
WLH
$2.21M 0.02%
+76,094
New +$2.06M
BCRX icon
328
BioCryst Pharmaceuticals
BCRX
$2.36B
$2.21M 0.02%
450,000
– –
SAIL
329
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$2.17M 0.02%
+150,000
New +$2.2M
KTWO
330
DELISTED
K2M Group Holdings, Inc
KTWO
$2.14M 0.02%
+118,941
New +$2.26M
OMED
331
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$2.14M 0.02%
521,883
– –
MXIM
332
DELISTED
Maxim Integrated Products
MXIM
$2.14M 0.02%
40,897
-471,110
-92% -$24.5M
TNDM icon
333
CALL
Tandem Diabetes Care
TNDM
$1.29B
$2.12M 0.02%
+900,000
New +$2.83M
CUDA
334
DELISTED
Barracuda Networks, Inc.
CUDA
$2.12M 0.02%
77,216
-100,227
-56% -$2.49M
SCPH
335
DELISTED
scPharmaceuticals
SCPH
$2.12M 0.02%
+175,000
New +$2.47M
KREF
336
KKR Real Estate Finance Trust
KREF
$478M
$2.06M 0.02%
102,989
-8,814
-8% -$182K
LUMO
337
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$2.03M 0.02%
+27,778
New +$2.3M
PWR icon
338
Quanta Services
PWR
$100B
$2.02M 0.02%
+51,666
New +$1.94M
CTSH icon
339
Cognizant
CTSH
$25.6B
$2M 0.02%
28,088
-1,114,958
-98% -$81.5M
IMDZ
340
DELISTED
Immune Design Corp.
IMDZ
$1.95M 0.02%
+500,000
New +$2.72M
RDN icon
341
Radian Group
RDN
$4.82B
$1.94M 0.02%
94,312
-63,708
-40% -$1.31M
BMCH
342
DELISTED
BMC Stock Holdings, Inc
BMCH
$1.94M 0.02%
+76,573
New +$1.72M
ARGX icon
343
argenx
ARGX
$54.8B
$1.9M 0.02%
30,100
-91,213
-75% -$2.99M
CFRX
344
CALL
DELISTED
ContraFect Corporation
CFRX
$1.89M 0.02%
2,344
– –
ATH
345
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$1.86M 0.01%
+35,965
New +$1.84M
BFH icon
346
Bread Financial
BFH
$4.44B
$1.83M 0.01%
9,069
-242
-3% -$44.8K
FATE icon
347
Fate Therapeutics
FATE
$290M
$1.83M 0.01%
+300,000
New +$1.34M
PNR icon
348
Pentair
PNR
$11.2B
$1.83M 0.01%
+38,605
New +$1.8M
MLM icon
349
Martin Marietta Materials
MLM
$32.3B
$1.73M 0.01%
7,831
-58,173
-88% -$12.2M
SGYP
350
CALL
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.67M 0.01%
+750,000
New +$1.86M
12 13
14
15 16

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM

Alyeska Investment Group's Q4 2017 Portfolio in Review

As of Q4 2017, Alyeska Investment Group held 605 positions worth $12.6B, down 6.1% from $13.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group withdrew a net $1.34B in Q4 2017, closing 185 positions and reducing 113 holdings. Its most notable exit was Texas Instruments, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Alyeska Investment Group opened a new position in IBM worth $272M.

  • Alyeska Investment Group's largest Q4 2017 buy was IBM: 1,851,994 shares worth $272M.
  • Alyeska Investment Group added most to KeyCorp in Q4 2017, an estimated $122M increase.
  • Alyeska Investment Group's biggest Q4 2017 reduction was Equinix, cutting an estimated $104M.
  • Alyeska Investment Group fully exited Texas Instruments in Q4 2017, selling an estimated $213M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $12.6B portfolio in Q4 2017.
  • Alyeska Investment Group opened 149 new positions and closed 185 in Q4 2017.
  • Alyeska Investment Group's portfolio value fell 6.1% quarter-over-quarter to $12.6B.

Based on Alyeska Investment Group's 13F filing for Q4 2017, filed 14 Feb 2018.